WO2001098478A3 - Clk-2, cex-7 and coq-4 genes, and uses thereof - Google Patents

Clk-2, cex-7 and coq-4 genes, and uses thereof Download PDF

Info

Publication number
WO2001098478A3
WO2001098478A3 PCT/CA2001/000913 CA0100913W WO0198478A3 WO 2001098478 A3 WO2001098478 A3 WO 2001098478A3 CA 0100913 W CA0100913 W CA 0100913W WO 0198478 A3 WO0198478 A3 WO 0198478A3
Authority
WO
WIPO (PCT)
Prior art keywords
gene
clk
coq
cex
present
Prior art date
Application number
PCT/CA2001/000913
Other languages
French (fr)
Other versions
WO2001098478A2 (en
Inventor
Siegfried Hekimi
Claire Benard
Brent Mccright
Bernard Lakowski
Dong Han
Jean-Claude Labbe
Original Assignee
Univ Mcgill
Siegfried Hekimi
Claire Benard
Brent Mccright
Bernard Lakowski
Dong Han
Jean-Claude Labbe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mcgill, Siegfried Hekimi, Claire Benard, Brent Mccright, Bernard Lakowski, Dong Han, Jean-Claude Labbe filed Critical Univ Mcgill
Priority to CA002413452A priority Critical patent/CA2413452A1/en
Priority to IL15357301A priority patent/IL153573A0/en
Priority to US10/312,187 priority patent/US20030162291A1/en
Priority to AU2001272238A priority patent/AU2001272238A1/en
Priority to JP2002504626A priority patent/JP2004500878A/en
Priority to EP01951254A priority patent/EP1325124A2/en
Publication of WO2001098478A2 publication Critical patent/WO2001098478A2/en
Priority to US10/349,507 priority patent/US20030199002A1/en
Publication of WO2001098478A3 publication Critical patent/WO2001098478A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • C07K14/43545—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes from Caenorhabditis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

The present invention relates to a clk-2 gene which has a function at the level of cellular physiology involved in developmental rate, telomere length and longevity, wherein clk-2 mutations cause a longer life, an altered cellular metabolism and an altered telomere length relative to the wild type, wherein clk-2 overexpression leads to telomere shortening. The present invention also relates to clk-2 co-expressed gene which comprises a cex-7 gene having the nucleotide sequence set forth in Fig. 33 which codes for a CEX-7 protein having the amino acid sequence set forth in Fig. 34 wherein said gene is located in the clk-2 operon and said cex-7 gene is transcriptionally co-expressed with clk-2 gene present in said operon. The present invention also relates to a coq-4 gene which has a function at the level of cellular physiology involved in the regulation of developmental rate and longevity, wherein coq-4 mutations cause altered cellular metabolism and physiological relative to the wild type, wherein coq-4 gene has the identifying characteristics of nucleotide sequence set forth in Fig. 36.
PCT/CA2001/000913 2000-06-22 2001-06-20 Clk-2, cex-7 and coq-4 genes, and uses thereof WO2001098478A2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
CA002413452A CA2413452A1 (en) 2000-06-22 2001-06-20 Clk-2, cex-7 and coq-4 genes, and uses thereof
IL15357301A IL153573A0 (en) 2000-06-22 2001-06-20 Clk-2, cek-7 and coq-4 genes, and uses thereof
US10/312,187 US20030162291A1 (en) 2000-06-22 2001-06-20 Clk-2, cex-7 and coq-4 genes, and uses thereof
AU2001272238A AU2001272238A1 (en) 2000-06-22 2001-06-20 CLK-2, CEX-7 and COQ-4 genes, and uses thereof
JP2002504626A JP2004500878A (en) 2000-06-22 2001-06-20 CLK-2, CEX-7 and COQ-4 genes and uses thereof
EP01951254A EP1325124A2 (en) 2000-06-22 2001-06-20 Clk-2, cex-7 and coq-4 genes, and uses thereof
US10/349,507 US20030199002A1 (en) 2000-06-22 2003-01-22 Clk-2 nucleic acids, polypeptides and uses thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21317400P 2000-06-22 2000-06-22
US60/213,174 2000-06-22
US25493200P 2000-12-13 2000-12-13
US60/254,932 2000-12-13

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10/312,187 A-371-Of-International US20030162291A1 (en) 2000-06-22 2001-06-20 Clk-2, cex-7 and coq-4 genes, and uses thereof
US10/349,507 Continuation-In-Part US20030199002A1 (en) 2000-06-22 2003-01-22 Clk-2 nucleic acids, polypeptides and uses thereof

Publications (2)

Publication Number Publication Date
WO2001098478A2 WO2001098478A2 (en) 2001-12-27
WO2001098478A3 true WO2001098478A3 (en) 2003-05-01

Family

ID=26907831

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2001/000913 WO2001098478A2 (en) 2000-06-22 2001-06-20 Clk-2, cex-7 and coq-4 genes, and uses thereof

Country Status (7)

Country Link
US (2) US20030162291A1 (en)
EP (1) EP1325124A2 (en)
JP (1) JP2004500878A (en)
AU (1) AU2001272238A1 (en)
CA (1) CA2413452A1 (en)
IL (1) IL153573A0 (en)
WO (1) WO2001098478A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030162291A1 (en) * 2000-06-22 2003-08-28 Seigfried Hekimi Clk-2, cex-7 and coq-4 genes, and uses thereof
US8450302B2 (en) * 2002-08-02 2013-05-28 Ab Science 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
US7329495B2 (en) 2004-06-09 2008-02-12 Board Of Regents, The University Of Texas System Mutations in KIT confer imatinib resistance in gastrointestinal stromal tumors
US8361976B2 (en) 2004-07-09 2013-01-29 University Of Massachusetts Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference molecules
WO2006037224A1 (en) * 2004-10-06 2006-04-13 Mcgill University Isolated clk-1 -i- cells from clk-1 heterozygous animals and their use in treating oxidative stress disorders
AU2006218407B2 (en) * 2005-03-03 2012-11-15 Sirtris Pharmaceuticals, Inc. Fluorescence polarization assays for acetyltransferase/deacetylase activity
US20090298062A1 (en) 2005-09-21 2009-12-03 Hiroshima University Method for determination of the length of the g-tail sequence and kit for the method
US20070248590A1 (en) * 2005-12-02 2007-10-25 Sirtris Pharmaceuticals, Inc. Modulators of CDC2-like kinases (CLKS) and methods of use thereof
ES2389111T3 (en) * 2005-12-02 2012-10-23 Sirtris Pharmaceuticals, Inc. Mass spectrometry assays for acetyltransferase / deacetylase activity
TW201627320A (en) 2007-02-02 2016-08-01 艾瑟勒朗法瑪公司 Variants derived from ActRIIB and uses therefor

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998017823A1 (en) * 1996-10-21 1998-04-30 Mcgill University STRUCTURAL AND FUNCTIONAL CONSERVATION OF THE C. ELEGANS CLOCK GENE $i(clk-1)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030162291A1 (en) * 2000-06-22 2003-08-28 Seigfried Hekimi Clk-2, cex-7 and coq-4 genes, and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998017823A1 (en) * 1996-10-21 1998-04-30 Mcgill University STRUCTURAL AND FUNCTIONAL CONSERVATION OF THE C. ELEGANS CLOCK GENE $i(clk-1)

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
BENARD CLAIRE ET AL: "The C. elegans maternal-effect gene clk-2 is essential for embryonic development, encodes a protein homologous to yeast Tel2p and affects telomere length.", DEVELOPMENT (CAMBRIDGE), vol. 128, no. 20, October 2001 (2001-10-01), pages 4045 - 4055, XP002219461, ISSN: 0950-1991 *
DATABASE EMBL [online] 10 September 1997 (1997-09-10), KOHARA Y.: "C.elegans cDNA clone yk447b4 : 5' end, single read.", XP002219463, retrieved from EBI Database accession no. C47479 *
DATABASE EMBL [online] 19 July 1999 (1999-07-19), KOHARA Y: "Caenorhabditis elegans cDNA clone:yk525h3 : 5' end, single read.", XP002219464, retrieved from EBI Database accession no. AV188553 *
DATABASE EMBL [online] 25 March 1999 (1999-03-25), WATERSTON R.: "Caenorhabditis elegans cosmid C07H6, complete sequence.", XP002219462, retrieved from EBI Database accession no. AC006605 *
DATABASE SWALL [online] 1 October 1996 (1996-10-01), RUNGE K. ET AL.: "Telomere length regulation protein TEL2", XP002219465, retrieved from EBI Database accession no. P53038 *
HARLEY C B: "TELOMERE LOSS:MITOTIC CLOCK OR GENETIC TIME BOMB?", MUTATION RESEARCH, AMSTERDAM, NL, vol. 256, 1991, pages 271 - 282, XP000198997, ISSN: 0027-5107 *
HEKIMI S ET AL: "Molecular genetics of life span in C. elegans: how much does it teach us?", TRENDS IN GENETICS, ELSEVIER SCIENCE PUBLISHERS B.V. AMSTERDAM, NL, vol. 14, no. 1, 1998, pages 14 - 20, XP004101479, ISSN: 0168-9525 *
HEKIMI SIEGFRIED ET AL: "Viable maternal-effect mutations that affect the development of the nematode Caenorhabditis elegans.", GENETICS, vol. 141, no. 4, 1995, pages 1351 - 1364, XP002219459, ISSN: 0016-6731 *
LAKOWSKI ET AL: "Determination of life-span in Caenorhabditis elegans by four clock genes", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 272, 17 May 1996 (1996-05-17), pages 1010 - 1013, XP002089004, ISSN: 0036-8075 *
RUNGE KURT W ET AL: "TEL2, an essential gene required for telomere length regulation and telomere position effect in Saccharomyces cerevisiae.", MOLECULAR AND CELLULAR BIOLOGY, vol. 16, no. 6, 1996, pages 3094 - 3105, XP002219460, ISSN: 0270-7306 *
THE C ELEGANS SEQUENCING CONSORTIUM: "Genome sequence of the nematode C. elegans: a platform for investigating biology", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 282, 11 December 1998 (1998-12-11), pages 2012 - 2018, XP002195036, ISSN: 0036-8075 *
WONG A ET AL: "MUTATIONS IN THE CLK-1 GENE OF CAENORHABDITIS ELEGANS AFFECT DEVELOPMENTAL AND BEHAVIORAL TIMING", GENETICS, GENETICS SOCIETY OF AMERICA, AUSTIN, TX, US, vol. 139, no. 3, 1 March 1995 (1995-03-01), pages 1247 - 1259, XP002054192, ISSN: 0016-6731 *

Also Published As

Publication number Publication date
AU2001272238A1 (en) 2002-01-02
JP2004500878A (en) 2004-01-15
US20030162291A1 (en) 2003-08-28
CA2413452A1 (en) 2001-12-27
EP1325124A2 (en) 2003-07-09
US20030199002A1 (en) 2003-10-23
IL153573A0 (en) 2003-07-06
WO2001098478A2 (en) 2001-12-27

Similar Documents

Publication Publication Date Title
HK1153508A1 (en) Urate oxidase
WO2001098478A3 (en) Clk-2, cex-7 and coq-4 genes, and uses thereof
MXPA01008372A (en) Fucosyl transferase gene.
EP1622921A4 (en) Variants of beta-glucosidases
IN2014DN02483A (en)
EP1146052A3 (en) Arthropod defensins
NZ508439A (en) Novel endometriosis-associated gene
CA2281206A1 (en) Geranyl diphosphate synthase genes
EP1849868A3 (en) Plant defensins
WO2003014350A1 (en) Novel rice gene regulating salt stress tolerance
WO2002066636A3 (en) T cell receptor variants expressed in mesenchymal cells and uses thereof
ZA97835B (en) Purified sr-p70 protein
WO2001025455A3 (en) Promoter for regulating expression of foreign genes
WO2003048325A3 (en) Nucleotide sequences of shrimp beta-actin and actin promoters and their use in genetic transformation technology
WO2003029469A1 (en) Novel selenocystein-containing proteins
WO1999053069A3 (en) Cell cycle regulatory proteins cdc2 and pitslre from plants
WO2003031459A3 (en) Modulation of the expression of genes dependent on stat-1
WO2000028036A3 (en) Disease resistance factors
WO2003047532A3 (en) Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition
EP2055779A3 (en) Auxin transport proteins
WO2003089613A3 (en) Tocopherol associated protein and uses thereof
AU2001276385A1 (en) Nucleotide sequences which code for the lysr3 gene
WO1999048486A3 (en) Plant cell cyclin genes
MXPA01011563A (en) A novel factor-h related protein 5 and antobodies thereto.
WO2001053470A3 (en) Nucleic acid and amino acid sequences encoding a de novo dna methyltransferase

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref country code: JP

Ref document number: 2002 504626

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2413452

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 153573

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2001951254

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2001272238

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 10312187

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001951254

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001951254

Country of ref document: EP